- The Firm
- Case Studies
SSCO Shanghai Head Office
Stenvall Skoeld & Company (China) Limited
4th Floor 139 No. 1 Ruijin Road
Huangpu District, Shanghai
Tel: +86 (21) 6136 6008
China M&A Week in Review is SSCO’s weekly summary of deals and key developments in China related Mergers and Acquisitions. Our emphasis is on cross-border deals.
This Week’s Links
Outbound M&A and Investment
Manchester City: Chinese investors pay $400m for 13% stake, Financial Times,1/12/2015 “A consortium led by private equity groups China Media Capital and CITIC Capital will pay $400m for the stake in City Football Group, which also owns Melbourne City and New York City football clubs, and is a minority shareholder in Japan’s Yokohama F. Marinos.”
Zimbabwe: Chinese Group Acquires Stake in Sunlight Energy: Allafrica, 2/12/2015 “Qingdao Hengshun Zhongsheng Group, headquartered in eastern China’s port city of Qingdao, disclosed on Tuesday that it had inked a memorandum of understanding with Coal of Africa in a deal worth 114 million US dollars.”
Zimbabwe: Chinese Group Acquires Stake in Sunlight Energy: Allafrica, 2/12/2015 “Yunnan Linkun Investment Group of China has acquired a 50 percent shareholding in China-Africa Sunlight Energy and plans to invest an initial $700 million towards the development of Gwayi Coal-Electricity Integrated Project in Matabeleland North Province.”
China Three Gorges’ acquisition of hydro-projects in Brazil will increase leverage; rating unaffected: Moody’s, 4/12/2015 “CTG announced that it had won the auction for a 30-year concession of two hydroelectric power plants in Brazil for BRL13.8 billion ($3.7 billion). Beginning 1 January 2016, CTG will operate the Jupiá and Ilha Solteira dams, which are debt-free, operating projects with 1.55GW and 3.44GW of installed capacity, respectively.”
Luye Medical to buy Healthe Care Australia in $700m deal: Financial Times, 5/12/2015 “Chinese pharmaceuticals group Luye Medical will buy Australian private hospital operator Healthe Care Australia in a $700m deal that underlines the ambitions of China’s healthcare industry for expansion as well as its interest in acquiring expertise to bring home.”
About Stenvall Skoeld & Company
Stenvall Skoeld & Company (SSCO) is an M&A advisory firm with global reach on cross-border transactions. We act as financial advisors to buyers and sellers on mergers, acquisitions, divestitures, capital raises and other strategic and financial transactions and investment decisions. We specialize in cross-border transactions involving Asia, China in particular.
Contact us for more information.
Our ViewOur team-members' views and reflections on China-related mergers and acquisitions (M&A) – including inbound foreign investment and outbound Chinese M&A – and other China-related business issues.